• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[儿童葡萄膜炎的临床特征与治疗]

[Clinical features and therapy of uveitis in childhood].

作者信息

Kiss Judit, Gaál Valéria, Nyul Zoltán, Mosdósi Bernadett

机构信息

Klinikai Központ, Gyermekgyógyászati Klinika, Pécsi Tudományegyetem, Általános Orvostudományi Kar Pécs.

Klinikai Központ, Szemészeti Klinika, Pécsi Tudományegyetem, Általános Orvostudományi Kar Pécs.

出版信息

Orv Hetil. 2019 Aug;160(34):1335-1339. doi: 10.1556/650.2019.31459.

DOI:10.1556/650.2019.31459
PMID:31423830
Abstract

Uveitis is characterized by inflammation of the middle layer of the eye. Its overall incidence is low. Autoimmune diseases and infections are the most common underlying diseases. Out of the autoimmune diseases, juvenile idiopathic arthritis is associated most frequently with uveitis. The topical ophthalmological treatment may fail in a significant proportion of the patients and immunomodulatory therapy may be required. In a retrospective study, data of 33 children diagnosed and treated with uveitis at the Department of Pediatrics and Ophthalmology, University of Pécs during the last 5 years were collected and analyzed. The mean age of the patients was 9.3 (0.3-17.8) years. Boys and girls were equally affected with an exception of patients with juvenile idiopathic arthritis where female predominance was found. An underlying disease could be identified in 60% of the cases (20/33). Uveitis was associated in 12 patients with juvenile idiopathic arthritis, in 2 patients with Behcet's disease and in a single case with inflammatory bowel disease. Infections have been proven in 5 patients. The autoimmune diseases caused an eye inflammation typically in anterior localization, in contrast to the infections that resulted in posterior uveitis. The majority of the patients required systemic treatment. 3 of them received systemic corticosteroid and 18 patients methotrexate as disease-modifying antirheumatic drug. 13 children with severe disease activity required biological therapy (adalimumab injection). Remission could be achieved in 1.45 (0.75-2.5) months. Pediatric uveitis is of great importance. Early diagnosis, adequate therapy and follow-up require multidisciplinary cooperation. Orv Hetil. 2019; 160(34): 1335-1339.

摘要

葡萄膜炎的特征是眼球中层发炎。其总体发病率较低。自身免疫性疾病和感染是最常见的潜在病因。在自身免疫性疾病中,幼年特发性关节炎与葡萄膜炎的关联最为频繁。相当一部分患者的局部眼科治疗可能无效,可能需要免疫调节治疗。在一项回顾性研究中,收集并分析了过去5年在佩奇大学儿科和眼科诊断和治疗的33例葡萄膜炎患儿的数据。患者的平均年龄为9.3(0.3 - 17.8)岁。除幼年特发性关节炎患者中女性占优势外,男孩和女孩受影响的程度相同。60%(20/33)的病例可确定有潜在病因。12例葡萄膜炎患者与幼年特发性关节炎有关,2例与白塞病有关,1例与炎症性肠病有关。5例患者已证实有感染。自身免疫性疾病通常引起前部葡萄膜炎,而感染则导致后部葡萄膜炎。大多数患者需要全身治疗。其中3例接受全身皮质类固醇治疗,18例接受甲氨蝶呤作为改善病情的抗风湿药物治疗。13例疾病活动严重的儿童需要生物治疗(注射阿达木单抗)。1.45(0.75 - 2.5)个月可实现缓解。儿童葡萄膜炎非常重要。早期诊断、适当治疗和随访需要多学科合作。《匈牙利医学周报》。2019年;160(34):1335 - 1339。

相似文献

1
[Clinical features and therapy of uveitis in childhood].[儿童葡萄膜炎的临床特征与治疗]
Orv Hetil. 2019 Aug;160(34):1335-1339. doi: 10.1556/650.2019.31459.
2
Safety of weekly adalimumab in the treatment of juvenile idiopathic arthritis and pediatric chronic uveitis.阿达木单抗每周治疗对幼年特发性关节炎和儿童慢性葡萄膜炎的安全性。
Clin Rheumatol. 2018 Feb;37(2):549-553. doi: 10.1007/s10067-017-3890-4. Epub 2017 Nov 4.
3
Ocular threat in juvenile idiopathic arthritis.青少年特发性关节炎中的眼部威胁
Joint Bone Spine. 2009 Jul;76(4):383-8. doi: 10.1016/j.jbspin.2008.10.015. Epub 2009 Jun 12.
4
The effect of anti-tumor necrosis factor alpha agents on the outcome in pediatric uveitis of diverse etiologies.抗肿瘤坏死因子α制剂对不同病因小儿葡萄膜炎治疗结果的影响。
Graefes Arch Clin Exp Ophthalmol. 2018 Apr;256(4):801-808. doi: 10.1007/s00417-018-3928-6. Epub 2018 Feb 18.
5
Efficacy of adalimumab in young children with juvenile idiopathic arthritis and chronic uveitis: a case series.阿达木单抗治疗幼年特发性关节炎合并慢性葡萄膜炎幼儿的疗效:病例系列
BMC Res Notes. 2014 May 24;7:316. doi: 10.1186/1756-0500-7-316.
6
Predictive factors and biomarkers for the 2-year outcome of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with Juvenile Idiopathic Arthritis (ICON-JIA) study.幼年特发性关节炎葡萄膜炎 2 年结局的预测因素和生物标志物:幼年特发性关节炎(ICON-JIA)新诊断患者队列研究的数据。
Rheumatology (Oxford). 2019 Jun 1;58(6):975-986. doi: 10.1093/rheumatology/key406.
7
Importance of pediatric rheumatologists and transitional care for juvenile idiopathic arthritis-associated uveitis: a retrospective series of 9 cases.儿科风湿病学家和青少年特发性关节炎相关葡萄膜炎过渡护理的重要性:9 例回顾性系列研究。
Pediatr Rheumatol Online J. 2020 Mar 23;18(1):26. doi: 10.1186/s12969-020-0419-1.
8
Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis.青少年特发性关节炎相关葡萄膜炎中的抗阿达木单抗抗体。
Clin Exp Rheumatol. 2017 Nov-Dec;35(6):1043-1046. Epub 2017 Nov 14.
9
Adalimumab plus Methotrexate for Uveitis in Juvenile Idiopathic Arthritis.阿达木单抗联合甲氨蝶呤治疗幼年特发性关节炎相关葡萄膜炎。
N Engl J Med. 2017 Apr 27;376(17):1637-1646. doi: 10.1056/NEJMoa1614160.
10
Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated with Juvenile Idiopathic Arthritis.阿达木单抗和英夫利昔单抗治疗幼年特发性关节炎相关葡萄膜炎的长期安全性和疗效。
J Rheumatol. 2018 Aug;45(8):1167-1172. doi: 10.3899/jrheum.171006. Epub 2018 Apr 15.